Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 45 articles for GARS

Then save them, add them to a collection or cite them together.
  1. Conference abstract · 22 Jun 2013

    Genetic Addiction Risk Scores (GARS) coupled with the Comprehensive Analysis of Reported Drugs (CARD) provide diagnostic and outcome data supporting the need for dopamine D2 agonist therapy: Proposing a holistic -therapeutic model for Reward Deficiency Syndrome (RDS)

    Journal of Addiction Research & Therapy

    underway reveal the important utility of a novel panel of candidate genes termed GARS enabling the stratification of genetically based severity of addiction liability. One study performed in both ... United States and…

  2. Conference abstract · 19 Nov 2012

    Coupling the Genetic Addiction Risk Score (GARS),™ Comprehensive Analysis of Reported Drugs (CARD)™ and KB220Z™ showing reward circuitry activation of dopaminergic pathways in Reward Deficiency Syndrome (RDS): A paradigm

    Journal of Genetic Syndromes & Gene Therapy

    others have been interested in developing a number of important tools to accurately diagnose (GARS?) , evaluate compliance to treatment medications and abstinence during treatment(CARD?) and enhance the quality…

  3. Research article · 30 Nov 2020

    Introducing Precision Addiction Management (PAM) utilizing polymorphic matched algorithms and Pro-Dopamine regulation to combat Reward Deficiency Behaviors (RDS) including Substance Use Disorder (SUD) globally

    Journal of Cognitive Neuropsychology

    Marjorie Gondré-Lewis. The grant explores utilization of the Genetic Addiction Risk Score (GARS®) and the neuronutrient prodopamine regulator KB220. The development of GARS followed seminal research in 1990, whereby…

  4. Conference abstract · 28 Jan 2020

    Introducing and#8220;Precision Addiction Management (PAMandreg;)and#8221; utilizing polymorphic matched alogarithms and Pro-Dopamine regulation to combat Reward Deficiency Behaviors (RDS) including Substance Use Disorder (SUD) globally

    Journal of Clinical Psychiatry and Neuroscience

    Marjorie Gondre-Lewis. The grant explores utilization of the Genetic Addiction Risk Score (GARS®) and the neuronutrient prodopamine regulator KB220. The development of GARS followed seminal research in 1990, whereby…

  5. Conference abstract · 27 Aug 2014

    Genetic addiction risk score (GARSrx), comprehensive analysis of reported drugs (CARD) dopamine agonist therapy (kb220z): Embracing genetic prediction of addiction risk severity for pain and addiction treatment

    Journal of Addiction Research & Therapy

    functional connectivity of the brain reward circuitry. Study S1 is genetic addiction risk (GARS) stratification for Reward Deficiency Syndrome (RDS). The genetic polymorphisms [ DRD1=G; DRD2=AI; DRD3=C; DRD4…

  6. Conference abstract · 27 Aug 2014

    Genetic addiction risk score (GARSrx), comprehensive analysis of reported drugs (CARD) dopamine agonist therapy (kb220z): Embracing genetic prediction of addiction risk severity for pain and addiction treatment

    Journal of Addiction Research & Therapy

    functional connectivity of the brain reward circuitry. Study S1 is genetic addiction risk (GARS) stratification for Reward Deficiency Syndrome (RDS). The genetic polymorphisms [ DRD1=G; DRD2=AI; DRD3=C; DRD4…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels